MENU
+Compare
EDGE
ETF ticker: BATS
AS OF
Oct 16 closing price
Price
$42.92
Change
+$0.49 (+1.15%)

EDGE stock forecast, quote, news & analysis

The investment seeks capital appreciation... Show more

Category: #Trading
EDGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for EDGE with price predictions
Oct 16, 2025

Momentum Indicator for EDGE turns negative, indicating new downward trend

EDGE saw its Momentum Indicator move below the 0 level on October 10, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator turned negative. In of the 7 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDGE advanced for three days, in of 27 cases, the price rose further within the following month. The odds of a continued upward trend are .

EDGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 64 cases where EDGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Industry description

The investment seeks capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposure, the fund will primarily invest in one or more ETFs or options on an ETF or index (each, a “reference asset”). The fund is non-diversified.
View a ticker or compare two or three
EDGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of linical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Category Trading

Profile
Fundamentals
Details